The Global Healthcare CRO Market size is expected to reach $57.1 billion by 2025, rising at a market growth of 6.8% CAGR during the forecast period

    NEXT STORY
    Additional Update on COVID-19 Compassionate Use with Opaganib in Israel Provided by RedHill Biopharma
    PREV STORY
    Press Release Oncology Venture is issuing 925,925 shares under its convertible note agreement with Negma Group LTD and Park Partners GB
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Sierra Oncology Appoints Christina Thomson as General Counsel

    author_avatar
    NASDAQ Market News

    TESARO, Inc. Gives Notice of Anticipated Make-Whole Adjustment Event to Holders of Its Convertible Senior Notes

    WALTHAM, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Ozempic® giver større vægttab hos voksne med type 2-diabetes og et BMI på 25 eller derover end dem med BMI under 25, viser en SUSTAIN 7 post hoc-analyse

    Bagsværd, den 23. juni 2018 ­- Ozempic® (semaglutid) 0,5 mg eller 1,0 mg medførte ...

    author_avatar
    NASDAQ Market News